GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 142 filers reported holding GOSSAMER BIO INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,366,857 | -35.0% | 1,646,815 | -6.0% | 0.00% | -25.0% |
| Q2 2023 | $2,101,338 | -5.8% | 1,751,115 | -1.1% | 0.00% | -20.0% |
| Q1 2023 | $2,230,721 | +1.2% | 1,770,413 | +74.3% | 0.01% | 0.0% |
| Q4 2022 | $2,203,527 | -63.2% | 1,015,450 | +103.3% | 0.01% | -61.5% |
| Q3 2022 | $5,986,000 | +105.6% | 499,556 | +43.7% | 0.01% | +116.7% |
| Q2 2022 | $2,911,000 | -41.4% | 347,751 | -39.2% | 0.01% | -33.3% |
| Q1 2022 | $4,965,000 | -23.3% | 572,072 | 0.0% | 0.01% | -25.0% |
| Q4 2021 | $6,471,000 | +2574.0% | 572,072 | +2871.5% | 0.01% | +1100.0% |
| Q3 2021 | $242,000 | +55.1% | 19,252 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $156,000 | -12.4% | 19,252 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $178,000 | -41.8% | 19,252 | -39.2% | 0.00% | -50.0% |
| Q4 2020 | $306,000 | -35.7% | 31,676 | -17.4% | 0.00% | -33.3% |
| Q3 2020 | $476,000 | – | 38,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,164,835 | $27,471,000 | 5.62% |
| Kynam Capital Management, LP | 1,832,704 | $15,908,000 | 5.16% |
| Octagon Capital Advisors LP | 2,563,138 | $22,248,000 | 4.81% |
| Ally Bridge Group (NY) LLC | 450,000 | $3,906,000 | 2.90% |
| HHLR ADVISORS, LTD. | 7,420,974 | $64,414,000 | 1.34% |
| Palo Alto Investors LP | 1,756,757 | $15,249,000 | 1.18% |
| Boxer Capital, LLC | 2,462,358 | $21,373,000 | 1.10% |
| Ikarian Capital, LLC | 775,315 | $6,730,000 | 0.88% |
| Artal Group S.A. | 2,358,968 | $20,476,000 | 0.86% |
| Birchview Capital, LP | 129,088 | $1,120,000 | 0.81% |